<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b0/9096244/2dbfc3a440f9/fonc-12-817916-g001.jpg"/> </div> <div class="text-side"> <h1>A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.</h1> <p>Histomorphology and immunohistochemistry in variably differentiated ESCC (own images, have not been published in elsewhere, the scale bar is 50 µm). (A) Highly differentiated ESCC (H&amp;E stain, ×200). (B) Moderately differentiated ESCC (H&amp;E stain, ×200). (C) Poorly differentiated ESCC (H&amp;E stain, × 200). (D) In this case of poorly differentiated ESCC, the positive index of Ki-67 reaches 50% (Envision stain, ×200). (E) Poorly differentiated ESCC cells are positive for CK5/6 (Envision stain, ×200). (F) Poorly differentiated ESCC cells are negative for CK7 (Envision stain, ×200).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35574327/" target="_blank">35574327</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>